Cite
The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity.
MLA
Zhai, Lili, et al. “The Nuclear Expression of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Invasive Primary Breast Tumors Is Associated with Chemotherapy Sensitivity.” Pathology - Research & Practice, vol. 211, no. 2, Feb. 2015, pp. 130–37. EBSCOhost, https://doi.org/10.1016/j.prp.2014.11.004.
APA
Zhai, L., Li, S., Li, X., Li, H., Gu, F., Guo, X., Liu, F., Zhang, X., & Fu., L. (2015). The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity. Pathology - Research & Practice, 211(2), 130–137. https://doi.org/10.1016/j.prp.2014.11.004
Chicago
Zhai, Lili, Shuai Li, Xiaoyan Li, Huilan Li, Feng Gu, Xiaojing Guo, Fangfang Liu, Xinmin Zhang, and Li Fu. 2015. “The Nuclear Expression of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Invasive Primary Breast Tumors Is Associated with Chemotherapy Sensitivity.” Pathology - Research & Practice 211 (2): 130–37. doi:10.1016/j.prp.2014.11.004.